<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04638452</url>
  </required_header>
  <id_info>
    <org_study_id>2020-A00693-36</org_study_id>
    <nct_id>NCT04638452</nct_id>
  </id_info>
  <brief_title>Evaluation of Behavioural Psycho &amp; Physiological Responses in People With ASD During a Blood Test in Routine Care Practice</brief_title>
  <acronym>AUTICOPP</acronym>
  <official_title>Evaluation of Behavioural, Psychological and Physiological Responses in People With Autism Spectrum Disorder (ASD) During a Blood Test in Routine Care Practice</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Charles Perrens, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Charles Perrens, Bordeaux</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The project is a prospective study designed to characterize behaviour and its&#xD;
      psycho-physiological correlates of participants with ASD (children and adults) in comparison&#xD;
      with subjects without ASD matched in age during blood test in common practice.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The project is a prospective study designed to characterize behaviour and its&#xD;
      psycho-physiological correlates of participants with ASD (children and adults) in comparison&#xD;
      with subjects without ASD matched in age during blood test in common practice.&#xD;
&#xD;
      The aim is to analyse in an automated and standardised way video recording during a blood&#xD;
      test performed as part of routine follow-up care for people presenting ASD (children and&#xD;
      adults), qualitative data (type of emotion) and quantitative (intensity)&#xD;
&#xD;
        1. Emotional facial reactions&#xD;
&#xD;
        2. Behavioural reactions (video recording of participants' movements)&#xD;
&#xD;
        3. Physiological reactions (wireless smart watch worn on the wrist)&#xD;
&#xD;
        4. Psychological reactions (self and hetero questionaires) to characterize the signs of&#xD;
           pain and anxiety associated with this situation)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 8, 2021</start_date>
  <completion_date type="Anticipated">February 28, 2024</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Epidemiology</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Facial expression during blood sample</measure>
    <time_frame>through study completion, an average of 1 to 6 months</time_frame>
    <description>Evaluation of facial expression during blood sample in people with ASD as compared to healthy people with Face reader, Noldus sofware.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Body movement during blood sample</measure>
    <time_frame>through study completion, an average of 1 to 6 months</time_frame>
    <description>Evaluation of body movement during blood sample in people with ASD as compared to healthy people with EMPATICA watch and Face, Legs, Activity, Cry, Consolabilty (FLACC) scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of emotion felt by participants during blood sample</measure>
    <time_frame>through study completion, an average of 1 to 6 months</time_frame>
    <description>Evaluation of emotion felt by participants (anxiety, stress, pain, apprehension…) during blood sample with implified Scale for Assessing Pain in Dyscommunicatives People with Autism Spectrum Disorders (ESSDA) and Pain Assessment Grid - Intellectual Disability (GEDDI) scales</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Autism Spectrum Disorder</condition>
  <arm_group>
    <arm_group_label>Epidemiology</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Video recording of face, body movements and physiological parameters (heart rate, conductance using a wireless watch) of the participants during the blood test Passing self and hetero questionnaires of temotion felt and perceived.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Video &amp; movements recording</intervention_name>
    <description>Video recording of face, body movements and physiological parameters (heart rate, conductance using a wireless watch) of the participants during the blood test</description>
    <arm_group_label>Epidemiology</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Questionnaires</intervention_name>
    <description>Passing self and hetero questionnaires of emotion felt and perceived.</description>
    <arm_group_label>Epidemiology</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        All participants :&#xD;
&#xD;
          -  Person over 6 years of age&#xD;
&#xD;
          -  Person who consent to participate in the study&#xD;
&#xD;
          -  Membership of the social security scheme&#xD;
&#xD;
          -  Person who not received analgesic treatment that may interfere with pain perception&#xD;
&#xD;
          -  Person with medical prescription for blood sample&#xD;
&#xD;
        Participants with ASD :&#xD;
&#xD;
          -  Person with ASD diagnosis&#xD;
&#xD;
          -  If applicable, legal authority consent to participate in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        All participants :&#xD;
&#xD;
          -  Person with unstabilized drug therapy&#xD;
&#xD;
          -  Person with acute or chronic pain&#xD;
&#xD;
          -  Person with pathology or receiving a treatment which can have an impact in&#xD;
             modification of the pain&#xD;
&#xD;
          -  Person with oculomotor and/or neuro-motor disorders&#xD;
&#xD;
          -  Pregnant or breastfeeding woman&#xD;
&#xD;
          -  Person with deprivation of liberty&#xD;
&#xD;
          -  Person who no consent to participate in the study or no consent to realised video&#xD;
             recording&#xD;
&#xD;
        Participants without ASD :&#xD;
&#xD;
          -  Protected adult&#xD;
&#xD;
          -  Person with ASD diagnosis&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anouck AMESTOY, MD</last_name>
    <role>Study Director</role>
    <affiliation>Physician</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anouck AMESTOY, MD</last_name>
    <phone>0556566719</phone>
    <email>aamestoy@ch-perrens.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>helen SAVARIEAU</last_name>
    <phone>0556563556</phone>
    <email>hsavarieau@ch-perrens.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre Hospitalier Charles PERRENS</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anouck AMESTOY, MD</last_name>
      <phone>05 56 56 67 19</phone>
      <email>aamestoy@ch-perrens.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <results_reference>
    <citation>Hilton CL, Harper JD, Kueker RH, Lang AR, Abbacchi AM, Todorov A, LaVesser PD. Sensory responsiveness as a predictor of social severity in children with high functioning autism spectrum disorders. J Autism Dev Disord. 2010 Aug;40(8):937-45. doi: 10.1007/s10803-010-0944-8.</citation>
    <PMID>20108030</PMID>
  </results_reference>
  <results_reference>
    <citation>Hirvikoski T, Mittendorfer-Rutz E, Boman M, Larsson H, Lichtenstein P, Bölte S. Premature mortality in autism spectrum disorder. Br J Psychiatry. 2016 Mar;208(3):232-8. doi: 10.1192/bjp.bp.114.160192. Epub 2015 Nov 5.</citation>
    <PMID>26541693</PMID>
  </results_reference>
  <results_reference>
    <citation>Breau LM, Camfield CS, McGrath PJ, Finley GA. The incidence of pain in children with severe cognitive impairments. Arch Pediatr Adolesc Med. 2003 Dec;157(12):1219-26.</citation>
    <PMID>14662579</PMID>
  </results_reference>
  <results_reference>
    <citation>Breau LM, Camfield CS, McGrath PJ, Finley GA. Risk factors for pain in children with severe cognitive impairments. Dev Med Child Neurol. 2004 Jun;46(6):364-71.</citation>
    <PMID>15174527</PMID>
  </results_reference>
  <results_reference>
    <citation>Dubois A, Rattaz C, Pry R, Baghdadli A. [Autism and pain - a literature review]. Pain Res Manag. 2010 Jul-Aug;15(4):245-53. Review. French.</citation>
    <PMID>20808970</PMID>
  </results_reference>
  <results_reference>
    <citation>Allely CS. Pain sensitivity and observer perception of pain in individuals with autistic spectrum disorder. ScientificWorldJournal. 2013 Jun 13;2013:916178. doi: 10.1155/2013/916178. Print 2013. Review.</citation>
    <PMID>23843740</PMID>
  </results_reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>October 15, 2020</study_first_submitted>
  <study_first_submitted_qc>November 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 20, 2020</study_first_posted>
  <last_update_submitted>August 17, 2021</last_update_submitted>
  <last_update_submitted_qc>August 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>autism spectrum disorders</keyword>
  <keyword>behaviour</keyword>
  <keyword>emotions</keyword>
  <keyword>Physiological reactions</keyword>
  <keyword>Psychological reactions</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Autistic Disorder</mesh_term>
    <mesh_term>Autism Spectrum Disorder</mesh_term>
    <mesh_term>Child Development Disorders, Pervasive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

